• Skip to content

Ceramisphere Health

<!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-163800918-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-163800918-1'); </script>

  • Home
  • About
    • Ceramisphere Health
    • History
    • People
    • Facilities
    • Technology
      • Ceramisphere Encapsulation Technology
      • Key Features and Benefits
  • Pipeline
    • Pipeline Overview
    • Lidocaine Patch
    • Controlled Drug Patch
    • EGF Patch
  • Investors
    • Technology Summary
    • Opportunity
    • Market & Opportunity for Lidocaine Patches
    • Market & Opportunity for Fentanyl Patches
    • Market & Opportunity for EGF Patches and Bioactive Wound Dressings
  • News
  • Downloads
  • Contact

Pipeline

Pipeline

PIPELINE OVERVIEW

Building on the key strengths of our silica delivery platform, such as protection and sustained release of the payload, and compatibility with spinning processes, Ceramisphere Health has developed the concept of a biodegradable nanocomposite patch in collaboration with Nanopharma a.s.

Our nanocomposite patches are composed of biodegradable polymeric nanofiber mat containing homogeneously distributed silica nano-particles containing the encapsulated bioactive/s.

They have the following distinctive features:

  • High Functionality incorporating a wide range of drugs, including drugs incompatible with the polymer matrix.
  • Exceptional protection of the active during and after production of the patch.
  • Extended sustained release provided by the silica nanoparticles.
  • Safe, Biocompatible and Non-toxic.
  • Prevents crystallisation of Poorly Soluble Drugs.
  • Efficient use of the whole drug payload with “minimal waste” after use.
CERAMISPHERE HEALTH
ADVANCED DRUG DELIVERY
We are an Australian based drug delivery company focused on the development of our “zero-waste” transdermal patches for the delivery of analgesics with an emphasis on controlled drugs for pain-relief and for development of smart bioactive wound care products with minimal pain and scarring. We are seeking partners to help us progress our “zero-waste” nanocomposite patch technology through early clinical trials with a view to license the technology for specific therapeutic applications to patch or wound dressing manufacturers or pharmaceutical companies.
Read More
  • Home
  • About
  • Contact
  • Downloads
COPYRIGHT © CERAMISPHERE 2023
Privacy Policy Terms & Conditions